Sugi Predict

Sugi Predict / Compounds / SCHEMBL5394485

SCHEMBL5394485

SCHEMBL5394485

C[C@]1(O)[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LGALS1 P09382 2/20 0.36
▸ LGALS3 P17931 2/20 0.36
▸ LGALS9 O00182 1/20 0.36
▸ LGALS8 O00214 1/20 0.36
▸ OGA O60502 7/20 0.35
▸ HEXB P07686 2/20 0.35
▸ HEXA P06865 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CA12 O43570 3/20 0.33
▸ CA1 P00915 3/20 0.33
▸ CA2 P00918 3/20 0.33
▸ CA9 Q16790 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ PYGB P11216 2/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29110844 1.00 LGALS1 (0.36) LGALS1LGALS3LGALS9LGALS8OGA
SCHEMBL10344857 1.00 LGALS1 (0.36) LGALS1LGALS3LGALS9LGALS8OGA
SCHEMBL6726689 1.00 LGALS1 (0.36) LGALS1LGALS3LGALS9LGALS8OGA
SCHEMBL4361557 1.00 LGALS1 (0.36) LGALS1LGALS3LGALS9LGALS8OGA
SCHEMBL6726688 1.00 LGALS1 (0.36) LGALS1LGALS3LGALS9LGALS8OGA
SCHEMBL5899047 1.00 LGALS1 (0.36) LGALS1LGALS3LGALS9LGALS8OGA
SCHEMBL338344 0.87 ADORA2A (0.38) LGALS1LGALS3LGALS9LGALS8OGA
SCHEMBL338345 0.87 ADORA2A (0.38) LGALS1LGALS3LGALS9LGALS8OGA
SCHEMBL14293911 0.87 ADORA2A (0.38) LGALS1LGALS3LGALS9LGALS8OGA
SCHEMBL1826901 0.87 ADORA2A (0.38) LGALS1LGALS3LGALS9LGALS8OGA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150265701-A1 IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR CANCURE LIMITED ACN 164 438 359 (AU) 2015-09-24 — — US claimed
US-20070207161-A1 Immunomodulating Compositions and uses Therefor CANCURE LIMITED ACN 164 438 359 (AU) 2007-09-06 — — US claimed
JP-2007508328-A — — 2007-04-05 — — JP claimed
EP-1682159-A1 IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR Ralph, John Stephen (AU) 2006-07-26 — — EP claimed
WO-2005037293-A1 IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR UNIV MONASH (AU) 2005-04-28 — — WO claimed
WO-2024104433-A1 USE OF GALECTIN-1 AS IMMUNE CHECKPOINT IN PREPARATION OF TUMOR IMMUNOTHERAPY MEDICAMENT AND MEDICAMENT 北京生命科学研究所 2024-05-23 — — WO disclosed
US-9770503-B2 Immunomodulating compositions and uses therefor CANCURE LIMITED ACN 164 438 359 (AU) 2017-09-26 — — US disclosed
EP-2591786-B1 Immunomodulating compositions and uses therefor CANCURE LTD (AU) 2017-04-12 — — EP disclosed
US-20150265701-A1 IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR CANCURE LIMITED ACN 164 438 359 (AU) 2015-09-24 — — US disclosed
US-9050352-B2 Immunomodulating compositions and uses therefor CANCURE LIMITED ACN 164 438 359 (AU) 2015-06-09 — — US disclosed
EP-2591786-A1 Immunomodulating compositions and uses therefor Ralph, Stephen John (AU) 2013-05-15 — — EP disclosed
US-20070207161-A1 Immunomodulating Compositions and uses Therefor CANCURE LIMITED ACN 164 438 359 (AU) 2007-09-06 — — US disclosed
EP-1682159-A1 IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR Ralph, John Stephen (AU) 2006-07-26 — — EP disclosed
WO-2005037293-A1 IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR UNIV MONASH (AU) 2005-04-28 — — WO disclosed